IP Library › Granted Patent US 12,225,889
Granted Patent B2
US 12,225,889 · App. 18/524,212 · Granted Feb 18, 2025

Pathogen-resistant animals having modified CD163 genes

Inventors: Randall S. Prather (Rocheport, MO); Kevin D. Wells (Columbia, MO); Kristin M. Whitworth (Columbia, MO)
Assignee: The Curators of the University of Missouri
A01K67/0276A01K67/02C07K14/70596C12N5/0609C12N5/061C12N5/10C12N9/22C12N15/09C12N15/8509C12N15/8778A01K2217/075A01K2227/108A01K2267/02C12N2310/20C12N2770/10011
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,225,889
App. No.
18/524,212
Granted
Feb 18, 2025
Kind
B2
Abstract

Non-human animals and offspring thereof comprising at least one modified chromosomal sequence in a gene encoding a CD163 protein are provided. Animal cells that contain such modified chromosomal sequences are also provided. The animals and cells have increased resistance to pathogens, including porcine reproductive and respiratory syndrome virus (PRRSV). The animals and offspring have chromosomal modifications of a CD163 gene. The invention further relates to methods of breeding to create pathogen-resistant animals and populations of animals made using such methods.

Claims (56)

1. A method of increasing porcine reproductive and respiratory (PRRS) resistance in a porcine animal, offspring, or cell, relative to a wild-type porcine animal, offspring, or cell, comprising:

modifying at least one chromosomal sequence in a gene encoding a CD163 protein in the porcine animal, offspring, or cell, wherein the modification is selected from the group consisting of:

a modification in exon 7 of the gene encoding the CD163 protein,

a modification in exon 8 of the gene encoding the CD163 protein,

a modification in an intron that is contiguous with exon 7 or exon 8 of the gene encoding the CD163 protein, and

a combination thereof, wherein the modification is selected from the group consisting of

an 11 bp deletion from nucleotide 3137 to nucleotide 3147 relative to the reference sequence SEQ ID NO:47,

a 377 bp deletion from nucleotide 2573 to nucleotide 2949, with a 2 bp addition between nucleotides 3149 to nucleotide 3150 relative to the reference sequence SEQ ID NO:47 on the same allele,

a 1930 base pair deletion from nucleotide 488 to nucleotide 2,417, wherein the deleted sequence is replaced with a 12 base pair insertion beginning at nucleotide 488, with a 129 base pair deletion from nucleotide 3044 to nucleotide 3172 relative to the reference sequence SEQ ID NO: 47 on the same allele,

a 1467 bp deletion from nucleotide 2,431 to nucleotide 3,897 relative to the reference sequence SEQ ID NO:47,

a 1280 bp deletion from nucleotide 2818 to nucleotide 4097 relative to the reference sequence SEQ ID NO:47, and

combinations thereof.

2. The method of claim 1 , wherein the porcine animal, offspring, or cell is heterozygous for the CD163 gene alteration.

3. The method of claim 1 , wherein the porcine animal, offspring, or cell is homozygous for the CD163 gene alteration.

4. The method of claim 1 , wherein the modification is produced by the action of a Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nuclease (TALEN) or Zinc Finger (ZFN) nuclease.

5. The method of claim 1 , wherein the deletion is selected from the group consisting of an 11 bp deletion from nucleotide 3137 to nucleotide 3147 relative to the reference sequence SEQ ID NO:47 and a 377 bp deletion from nucleotide 2573 to nucleotide 2949, with a 2 bp addition between nucleotides 3149 to nucleotide 3150 relative to the reference sequence SEQ ID NO:47 on the same allele.

6. The method of claim 5 , wherein the deletion deletes a Proline Serine Threonine domain.

7. The method of claim 6 , wherein the Proline Serine Threonine domain is a Proline Serine Threonine domain located after scavenger receptor cysteine-rich domain 6 or a Proline Serine Threonine domain located after scavenger receptor cysteine-rich domain 9.

8. A method of producing a porcine animal with increased porcine reproductive and respiratory (PRRS) resistance relative to a wild-type porcine animal comprising:

enucleating an oocyte;

fusing the oocyte with a donor somatic cell, the genome of the donor somatic cell comprising:

a modification in at least one chromosomal sequence in a gene encoding a CD163 protein, wherein the modification is selected from the group consisting of:

a modification in exon 7 of the gene encoding the CD163 protein,

a modification in exon 8 of the gene encoding the CD163 protein,

a modification in an intron that is contiguous with exon 7 or exon 8 of the gene encoding the CD163 protein, and

a combination thereof, wherein the modification is selected from the group consisting of

an 11 bp deletion from nucleotide 3137 to nucleotide 3147 relative to the reference sequence SEQ ID NO:47,

a 377 bp deletion from nucleotide 2573 to nucleotide 2949, with a 2 bp addition between nucleotides 3149 to nucleotide 3150 relative to the reference sequence SEQ ID NO:47 on the same allele,

a 1930 base pair deletion from nucleotide 488 to nucleotide 2,417, wherein the deleted sequence is replaced with a 12 base pair insertion beginning at nucleotide 488, with a 129 base pair deletion from nucleotide 3044 to nucleotide 3172 relative to the reference sequence SEQ ID NO: 47 on the same allele,

a 1467 bp deletion from nucleotide 2,431 to nucleotide 3,897 relative to the reference sequence SEQ ID NO:47,

a 1280 bp deletion from nucleotide 2818 to nucleotide 4097 relative to the reference sequence SEQ ID NO:47, and

combinations thereof;

activating the oocyte to produce an embryo; and

transferring the embryo into a reproductive tract of a surrogate porcine animal, wherein the surrogate porcine animal has initiated estrus but has not yet completed ovulation; and wherein gestation and term delivery produces a porcine animal with increased porcine reproductive and respiratory (PRRS) resistance relative to a wild-type porcine animal.

9. The method of claim 8 , wherein the porcine animal is homozygous for the modification.

10. The method of claim 8 , wherein the porcine animal is heterozygous for the modification.

11. The method of claim 8 , wherein the donor somatic cell comprises a fibroblast.

12. The method of claim 8 , wherein the deletion is selected from the group consisting of an 11 bp deletion from nucleotide 3137 to nucleotide 3147 relative to the reference sequence SEQ ID NO:47 and a 377 bp deletion from nucleotide 2573 to nucleotide 2949, with a 2 bp addition between nucleotides 3149 to nucleotide 3150 relative to the reference sequence SEQ ID NO:47 on the same allele.

13. The method of claim 12 , wherein the deletion deletes a Proline Serine Threonine domain.

14. The method of claim 13 , wherein the Proline Serine Threonine domain is a Proline Serine Threonine domain located after scavenger receptor cysteine-rich domain 6 or a Proline Serine Threonine domain located after scavenger receptor cysteine-rich domain 9.

15. A method for producing a genetically altered porcine animal comprising a modification in both chromosomal sequences in a gene encoding a CD163 protein, wherein the porcine animal exhibits increased resistance to porcine reproductive and respiratory syndrome virus (PRRSV) relative to a wild-type porcine animal, the method comprising:

mating a female genetically altered porcine animal produced by the method of claim 6 with a male genetically altered porcine animal produced by the method of claim 6 to produce F1 progeny; and

screening the F1 progeny to identify the genetically altered porcine animal comprising a modification in both chromosomal sequences in the gene encoding a CD163 protein, wherein the modification is selected from the group consisting of:

a modification in exon 7 of the gene encoding the CD163 protein,

a modification in exon 8 of the gene encoding the CD163 protein,

a modification in an intron that is contiguous with exon 7 or exon 8 of the gene encoding the CD163 protein, and

a combination thereof, wherein the modification is selected from the group consisting of

an 11 bp deletion from nucleotide 3137 to nucleotide 3147 relative to the reference sequence SEQ ID NO:47,

a 377 bp deletion from nucleotide 2573 to nucleotide 2949, with a 2 bp addition between nucleotides 3149 to nucleotide 3150 relative to the reference sequence SEQ ID NO:47 on the same allele,

a 1930 base pair deletion from nucleotide 488 to nucleotide 2,417, wherein the deleted sequence is replaced with a 12 base pair insertion beginning at nucleotide 488, with a 129 base pair deletion from nucleotide 3044 to nucleotide 3172 relative to the reference sequence SEQ ID NO: 47 on the same allele,

a 1467 bp deletion from nucleotide 2,431 to nucleotide 3,897 relative to the reference sequence SEQ ID NO:47,

a 1280 bp deletion from nucleotide 2818 to nucleotide 4097 relative to the reference sequence SEQ ID NO:47, and

combinations thereof.

16. The method of claim 15 , wherein the deletion is selected from the group consisting of an 11 bp deletion from nucleotide 3137 to nucleotide 3147 relative to the reference sequence SEQ ID NO:47 and a 377 bp deletion from nucleotide 2573 to nucleotide 2949, with a 2 bp addition between nucleotides 3149 to nucleotide 3150 relative to the reference sequence SEQ ID NO:47 on the same allele.

17. The method of claim 16 , wherein the deletion deletes a Proline Serine Threonine domain.

18. The method of claim 17 , wherein the Proline Serine Threonine domain is a Proline Serine Threonine domain located after scavenger receptor cysteine-rich domain 6 or a Proline Serine Threonine domain located after scavenger receptor cysteine-rich domain 9.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2023
From: PRATHER, RANDALL S.; WHITWORTH, KRISTIN; WELLS, KEVIN
To: THE CURATORS OF THE UNIVERSITY OF MISSOURI
Reel/Frame 065714/0312 →
Continuity (4)
Continuation 17036522 · Sep 29, 2020
Continuation 15750633
Provisional Application 62202145 · Aug 6, 2015
Related Publication 20240122164A1 · Apr 18, 2024
References Cited (180)
US 5945577A · Stice et al. · 1999 [cited by applicant]
US 6211429B1 · Machaty et al. · 2001 [cited by applicant]
US 9820475B2 · Prather · 2017 [cited by examiner]
US 10080353B2 · Prather · 2018 [cited by examiner]
US 10091975B2 · Prather · 2018 [cited by examiner]
US 10405526B2 · Prather · 2019 [cited by examiner]
US 10827730B2 · Prather · 2020 [cited by examiner]
US 11019809B2 · Prather · 2021 [cited by examiner]
US 11160260B2 · Prather · 2021 [cited by examiner]
US 20030237106A1 · Gorczynski · 2003 [cited by applicant]
US 20050120400A1 · Day et al. · 2005 [cited by applicant]
US 20050206017A1 · Ayares et al. · 2005 [cited by applicant]
US 20090104147A1 · Delpulte et al. · 2009 [cited by applicant]
US 20100158947A1 · Delputle et al. · 2010 [cited by applicant]
US 20110016543A1 · Weinstein et al. · 2011 [cited by applicant]
US 20110016546A1 · Bedell et al. · 2011 [cited by applicant]
US 20110038841A1 · Ayares · 2011 [cited by applicant]
US 20120180141A1 · Welsh et al. · 2012 [cited by applicant]
US 20130309263A1 · Calvert et al. · 2013 [cited by applicant]
US 20140096275A1 · Prather · 2014 [cited by examiner]
US 20180368374A1 · Prather et al. · 2018 [cited by applicant]
US 20210112790A1 · Prather · 2021 [cited by examiner]
US 20210259219A1 · Prather · 2021 [cited by examiner]
CN 104593422A · 2015 [cited by applicant]
JP 2014519323A · 2014 [cited by applicant]
WO 1996007732A1 · 1996 [cited by applicant]
WO 1997007668A1 · 1997 [cited by applicant]
WO 1997007669A1 · 1997 [cited by applicant]
WO 2005104835A2 · 2005 [cited by applicant]
WO 2012158828A1 · 2012 [cited by applicant]
WO 2015011483A1 · 2015 [cited by applicant]
WO 2015153647A1 · 2015 [cited by applicant]
WO 2016110214A1 · 2016 [cited by applicant]
WO 2017023337A1 · 2017 [cited by applicant]
WO 2017023570A1 · 2017 [cited by applicant]
Van Gorp H, Van Breedam W, Van Doorsselaere J, Delputte PL, Nauwynck HJ. Identification of the CD163 protein domains involved in infection of the porcine reproductive and respiratory syndrome virus. J Virol. Mar. 2010;8… [cited by examiner]
Ritter M, Buechler C, Langmann T, Schmitz G. Genomic organization and chromosomal localization of the human CD163 (M130) gene: a member of the scavenger receptor cysteine-rich superfamily. Biochem Biophys Res Commun. Ju… [cited by examiner]
Kim S, Kim D, Cho SW, Kim J, Kim JS. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res. Jun. 2014;24(6):1012-9. . Epub Apr. 2, 2014. (Year: 2014). [cited by examiner]
Lai L, Prather RS. Production of cloned pigs by using somatic cells as donors. Cloning Stem Cells. 2003;5(4):233-41. (Year: 2003). [cited by examiner]
Niu et al., Generation of Gene-Modified Cynomolgus Monkey via Cas9/RNA-Modified Gene Targeting in One-Cell Embryos; Cell, Feb. 13, 2014, vol. 156, pp. 836-843. [cited by applicant]
Nussbaum et al., Differential Effects of Protein Synthesis Inhibitors on Porcine Oocyte Activation; Molecular Reproduction and Development, 1995, vol. 41, pp. 70-75. [cited by applicant]
Oetke et al., Sialoadhesin-Deficient Mice Exhibit Subtle Changes in B- and T-Cell Populations and Reduced Immunoglobulin M Levels; Molecular and Cellular Biology, Feb. 2006, vol. 26, No. 4, pp. 1549-1557. [cited by applicant]
Paris et al., Equine Embryos and Embryonic Stem Cells: Defining Reliable Markers of Pluripotency; Theriogenology, 2010) vol. 74, pp. 516-524. [cited by applicant]
Park et al., Developmental Potential of Porcine Nuclear Transfer Embryos Derived from Transgenic Fetal Fibroblasts Infected with the Gene for the Green Fluorescent Protein: Comparison of Different Fusion/Activation Cond… [cited by applicant]
Park et al., Production of Nuclear Transfer-Derived Swine That Express the Enhanced Green Fluorescent Protein; Animal Biotechnology, 2001, vol. 12, No. 2, pp. 173-181. [cited by applicant]
Patience et al., Nutrition of the Breeding Herd; Swine Nutrition Guide, 1989, Chapter 6, pp. 149-171, Prairie Swine Centre, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. [cited by applicant]
Patton et al., Modulation of CD163 Receptor Expression and Replication of Porcine Reproductive and Respiratory Syndrome Virus in Porcine Macrophages; Virus Research, 2009, vol. 140, pp. 161-171. [cited by applicant]
Plagemann et al., Lactate Dehydrogenase-Elevating Virus and Related Viruses; In Fields Virology, 3rd Edition, Fields, B et al., ed, 1996, Chapter 36, pp. 1105-1120. [cited by applicant]
Popescu et al., Genetically Edited Pigs Lacking CD163 Show No Resistance Following Infection with the African Swine Fever Virus Isolate, Georgia 2007/1; Virology, 2017, vol. 501, pp. 102-106. [cited by applicant]
Ritter et al., Genomic organization and chromosomal localization of the human CD 163 (M 130) gene: a member of the scavenger receptor cysteine-rich superfamily. Biochem Biophys Res Commun., Jul. 5, 1999, vol. 260, No. 2… [cited by applicant]
Van Gorp et al., Identification of the CD163 protein domains involved in infection of the porcine reproductive and respiratory syndrome virus. J Viral., Mar. 2010, vol. 84, No. 6, pp. 3101-3105. Epub Dec. 23, 2009. [cited by applicant]
Wakchaure et al., Transgenic Animals: A Review on its Various Dimensions and Applications in Animal Biotechnology; Inl'l. Journal of Emerging Technology and Advanced Engineering, (2015), vol. 5, Issue 11, pp. 210-213. [cited by applicant]
Welch et al., A Brief Review of CD163 and its Role in PRRSV Infection; Virus Research, 2010, vol. 154, pp. 98-103. [cited by applicant]
Wells et al., Replacement of Porcine CD163 Scavenger Receptor Cysteine-Rich Domain 5 with a CD163-Like Homolog Confers Resistance of Pigs to Genotype 1 but Not Genotype 2 Porcine Reproductive and Respiratory Syndrome Vi… [cited by applicant]
Wensvoort et al. Mystery Swine Disease in The Netherlands: The Isolation of Lelystad Virus; Veterinary Quarterly, 1991, vol. 13, pp. 121-130. [cited by applicant]
Whitworth et al., Gene-edited Pigs Are Protected From Porcine Reproductive and Respiratory Syndrome Virus; Nature Biotechnology, Jan. 2016, vol. 34, No. 1, pp. 20-22. [cited by applicant]
Whitworth et al., Disruption the Sialoadhesin and CD163 Genes to Create Pigs Resistant to PRRSV infectivity; Abstract, Swine in Biomedical Research in Chicago, Illinois, Jul. 17-19, 2011, S1-25, pp. 39-40. [cited by applicant]
Whitworth et al., Activation Method Does Not Alter Abnormal Placental Gene Expression and Development in Cloned Pigs; Molecular Reproduction and Development, 2010, vol. 77, No. 12, pp. 1016-1030. [cited by applicant]
Whitworth et al., Pigs Resistant to PRRSV Infectivity; Poster Presented at Swine in Bio9medical Research in Chicago, Illinois, Jul. 18, 2011, 1-page. [cited by applicant]
Whitworth et al., Scriptaid Corrects Gene Expression of A Few Aberrantly Reprogrammed Transcripts in Nuclear Transfer Pig Blastocyst Stage Embryos; Cellular Reprogramming, 2011, vol. 13, No. 3, pp. 191-204. [cited by applicant]
Whitworth et al., Pigs Resistant to PRRSV Infectivity; University of Missouri Technology Transfer Showcase, 2012, 1 page. [cited by applicant]
Whitworth et al., Gene Editing as Applied to Prevention of Reproductive Porcine Reproductive and Respiratory Syndrome; Molecular Reproduction and Development, 2017, vol. 84, No. 9, pp. 926-933. [cited by applicant]
Whitworth et al., Use of the CRISPR/Cas9 System to Produce Genetically Engineered Pigs from In Vitro-Derived Oocytes and Embryos; Biology of Reproduction, 2014, vol. 91, No. 3, pp. 1-13. [cited by applicant]
Whitworth et al., Use of the CRISPR/Cas9 System to Produce Pigs With A Genetically Modified CD163 Gene by Using Somatic Cell Nuclear Transfer of In Vitro Derived Oocytes; Abstract, Swine in Biomedical Research Conferenc… [cited by applicant]
Whitworth et al., Use of the CRISPR/Cas9 System to Produce Pigs With A Genetically Modified CD163 3ene by Using Somatic Cell Nuclear Transfer of In Vitro Derived Oocytes; Poster, Swine in Biomedical Research Conference,… [cited by applicant]
Whitworth et al., Gene Editing of CD163 Protects Pigs from PRRSV Infectivity; Abstracts from the UC Davis Transgenic Animal Research Conference XI (Aug. 13-17, 2017), Transgenic Research, 2018, vol. 27, pp. 473-474. [cited by applicant]
Whyte et al., Genetic Modifications of Pigs for Medicine and Agriculture, Molecular Reproductive Development, 2011, vol. 78, Nos. (10-11), pp. 879-891. [cited by applicant]
Whyte et al., Gene Targeting With Zinc Finger Nucleases to Produce Cloned eGFP Knockout Pigs; Molecular Reproduction and Development, 2011, vol. 78, No. 1, 3-pages. [cited by applicant]
Whyte et al., Genetic Modifications of Pigs for Medicine and Agriculture; Molecular Reproduction and Development, 2011, vol. 78, No. 10-11, pp. 879-891. [cited by applicant]
Wiedenheft et al., RNA-guided Genetic Silencing Systems in Bacteria and Archaea; Nature, Feb. 2012, vol. 482, No. 7385; pp. 331-338. [cited by applicant]
Wills et al., Porcine Reproductive and Respiratory Syndrome Virus -A Persistent Infection; Veterinary Microbiology, 1997, vol. 55, No. 1-4, pp. 231-240. [cited by applicant]
Winckler et al., The Reliability and Repeatability of A Lameness Scoring System for Use as an Indicator of Welfare in Dairy Cattle; Acta Agriculturae Scandinavica, Section A-Animal Science, 2001, vol. 51, Supplement 30,… [cited by applicant]
Wissink et al., Identification of Porcine Alveolar Macrophage Glycoproteins Involved in Infection of Porcine Respiratory and Reproductive Syndrome Virus; Archives of Virology, 2003, vol. 148, No. 1, pp. 177-187. [cited by applicant]
Yang et al., Generation of PPAR(Gamma) Mono-Allelic Knockout Pigs Via Zinc-Finger Nucleases and Nuclear Transfer Cloning; Cell Research, 2011, vol. 6, pp. 979-982. [cited by applicant]
Yoon et al., Persistent and Contact Infection in Nursery Pigs Experimentally Infected with PRRS Virus; 1983, Swine Health and Production, vol. 1, pp. 5-8. [cited by applicant]
Yoshioka et al., Birth of Piglets Derived from Porcine Zygotes Cultured in A Chemically Defined Medium, Biology of Reproduction, 2002, vol. 66, pp. 112-119. [cited by applicant]
Zhang et al., PRRS Virus Receptors and Their Role for Pathogenesis; Veterinary Microbiology, 2015, vol. 177, pp. 229-241. [cited by applicant]
Zhao et al., Histone Deacetylase Inhibitors Improve In Vitro and In Vivo Developmental Competence of Somatic cell Nuclear Transfer Porcine Embryos; Cellular Reprogramming, 2010, vol. 12, No. 1, pp. 75-83. [cited by applicant]
Zhao et al., Significant Improvement in Cloning Efficiency of An Inbred Miniature Pig by Histone Deacetylase Inhibitor Treatment After Somatic Cell Nuclear Transfer; Biology of Reproduction; 2009, vol. 81, pp. 525-530. [cited by applicant]
Aigner et al., Transgenic Pigs as Models for Translational Biomedical Research; Journal of Molecular Medicine, (2010) vol. 88, No. 7, pp. 653-664. [cited by applicant]
Albina et al., Immune Response and Persistence of the Porcine Reproductive and Respiratory Syndrome Virus in Infected Pigs and Farm Units; The Veterinary Record, May 28, 1994, vol. 134, No. 22, pp. 567-573. [cited by applicant]
Allende et al., North American and European Porcine Reproductive and Respiratory Syndrome Viruses Differ in Non-Structural Protein Coding Regions; Journal of General Virology, 1999, vol. 80, pp. 307-315. [cited by applicant]
Allende et al., Porcine Reproductive and Respiratory Syndrome Virus: Description of Persistence in Individual Pigs Upon Experimental Infection, Journal of Virology, Nov. 2000, vol. 74, No. 22, pp. 10834-10837. [cited by applicant]
Andreyev et al., Genetic Variation and Phylogenetic Relationships of 22 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Field Strains Based on Sequence Analysis of Open Reading Frame 5, Archives of Virology,… [cited by applicant]
Bauer et al., Arginine Supplementation In Vitro Increases Porcine Embryo Development and Affects mRNA Transcript Expression; Reproduction, Fertility, and Development, 2011, vol. 23, pp. 107. [cited by applicant]
Beaton et al., Compound Transgenics: Recombinase-Mediated Gene Stacking; Transgenic Animal Technology, 2014, Chapter 21, pp. 565-578, Elsevier. [cited by applicant]
Benfield et al., Characterization of Swine Infertility and Respiratory Syndrome {SIRS) Virus (Isolate ATCC VR-2332); Journal of Veterinary Diagnostic Investigation, Apr. 1992, vol. 4, No. 2, pp. 127-133. [cited by applicant]
Benfield et al., Pathogenesis and Persistence of PRRS, Proceedings, Allen D. Leman Swine Conference, 1998, pp. 169-171. [cited by applicant]
Berg et al., 500-Biological Implications of Electric Field Effects, Part V. Fusion of Blastomeres and Blastocysts of Mouse Embryos; Bioelectrochemistry and Bioenergetics, 1982, vol. 9, pp. 223-228. [cited by applicant]
Boddicker et al., Genome-wide Association and Genomic Prediction for Host Response to Porcine Reproductive and Respiratory Syndrome Virus Infection; Genetics Selection Evolution, 2014, vol. 46, No. 18, 14-pages. [cited by applicant]
Borg et al., CD1d-lipid-antigen Recognition by the Semi-invariant NKT T-cell Receptor, Nature, Jul. 2007, vol. 448, No. 7149; pp. 44-49. [cited by applicant]
Brevini et al., No. Shortcuts to Pig Embryonic Stem Cell; Theriogenology, (2010) vol. 74, pp. 544-550. [cited by applicant]
Brinster et al., Factors Affecting the Efficiency of Introducing Foreign DNA Into Mice by Microinjecting Eggs; Proceedings of the National Academy of Sciences of the United States of America, Jul. 1985, vol. 82, No. 13,… [cited by applicant]
Burkard et al., Pigs Lacking the Scavenger Receptor Cysteine-Rich Domain 5 of CD163 Are Resistant to Porcine Reproductive and Respiratory Syndrome Virus 1 Infection; Journal of Virology, 2018, vol. 92, No. 16, 17-pages. [cited by applicant]
Burkard et al., Precision Engineering for PRRSV Resistance in Pigs: Macrophages from Genome Edited Pigs Lacking CD163 SRCR5 Domain are Fully Resistant to Both PRRSV Genotypes While Maintaining Biological Function, PLoS … [cited by applicant]
Calvert et al., CD163 Expression Confers Susceptibility to Porcine Reproductive and Respiratory Syndrome Viruses; Journal of Virology, Jul. 2007, vol. 81, No. 14, pp. 7371-7379. [cited by applicant]
Cao et al., Isolation and Culture of Primary Bovine Embryonic Stem Cell Colonies by a Novel Method; Journal of Experimental Zoology (2009) vol. 311A, pp. 368-376. [cited by applicant]
Carter et al., Phenotyping of Transgenic Cloned Piglets; Cloning and Stem Cells, 2002, vol. 4, No. 2, pp. 131-145. [cited by applicant]
Christopher-Hennings et al., Persistence of Porcine Reproductive and Respiratory Syndrome Virus in Serum and Semen of Adult Boars; Journal of Veterinary Diagnostic Investigation, Oct. 1995, vol. 7, No. 4, pp. 456-464. [cited by applicant]
Christopher-Hennings et al., Effects of A Modified-live Virus Vaccine Against Porcine Reproductive and Respiratory Syndrome in Boars, American Journal of Veterinary Research, 1997, vol. 58, No. 1, pp. 40-45. [cited by applicant]
Clark et al., A Future for Transgenic Livestock; Nature Reviews (2003) vol. 4, pp. 825-833. [cited by applicant]
Cong et al., Multiplex Genome Engineering Using CRISPR/Cas Systems, Science, 2013, vol. 339, No. 6121, pp. 819-823. [cited by applicant]
Crocker et al., Properties and Distribution of a Lectin-like Hemagglutinin Differentially Expressed by Murine 20 Stromal Tissue Macrophages; The Journal of Experimental Medicine, 1986, vol. 164, No. 6, pp. 1862-1875. [cited by applicant]
Crocker et al., Molecular Analysis of Sialoside Binding to Sialoadhesin by NMR and Site-directed Mutagenesis; Biochemical Journal, 1999, vol. 341, No. 2, pp. 355-361. [cited by applicant]
Dai et al., Targeted Disruption of the alpha1 ,3-galactosyltransferase Gene in Cloned Pigs; Nature Biotechnology, Mar. 2002, vol. 20, No. 3, pp. 251-255. [cited by applicant]
Das et al., The Minor Envelope Glycoproteins GP2a and GP4 of Porcine Reproductive and Respiratory Syndrome Virus Interact with the Receptor CD 163; Journal of Virology, Feb. 2010, vol. 84, No. 4, pp. 1731-1740. [cited by applicant]
Dee et al., Elimination of Porcine Reproductive and Respiratory Syndrome Virus Using A Test and Removal Process; The Veterinary Record, 1998, vol. 143, No. 17, pp. 474-476. [cited by applicant]
Delputte et al., Effect of Virus-specific Antibodies on Attachment, Internalization and Infection of Porcine Reproductive and Respiratory Syndrome Virus in Primary Macrophages, Veterinary Immunology and Immunopathology,… [cited by applicant]
Delputte et al., Involvement of the Matrix Protein in Attachment of Porcine Reproductive and Respiratory Syndrome Virus to a Heparinlike Receptor on Porcine Alveolar Macrophages; Journal of Virology, May 2002, vol. 76, … [cited by applicant]
Delputte et al., Porcine Arterivirus Infection of Alveolar Macrophages Is Mediated by Sialic Acid on the Virus; Journal of Virology, Aug. 2004, vol. 78, No. 15, pp. 8094-8101. [cited by applicant]
Delputte et al., Porcine Arterivirus Attachment to the Macrophage-Specific Receptor Sialoadhesin Is Dependent on the Sialic Acid-Binding Activity of the N-Terminal Immunoglobulin Domain of Sialoadhesin; Journal of Virol… [cited by applicant]
Delputte et al., Porcine Sialoadhesin (CD169/Siglec-1) Is an Endocytic Receptor that Allows Targeted Delivery of Toxins and Antigens to Macrophages, PLoS One, Feb. 2011, e16827, vol. 6, No. 2, pp. 1-12. [cited by applicant]
Etzerodt et al., Plasma Clearance of Hemoglobin and Haptoglobin in Mice and Effect of CD163 Gene Targeting Disruption; Antioxidants and Redox Signaling, 2013, vol. 18, No. 17, pp. 2254-2263. [cited by applicant]
Etzerodt et al., CD163 and Inflammation: Biological, Diagnostic, and Therapeutic Aspects; Antioxidants and Redox Signaling, 2013, vol. 18, No. 17, pp. 2352-2363. [cited by applicant]
Fabriek et al., The Macrophage Scavenger Receptor CD163; Immunobiology, 2005, vol. 210, No. 2-4, pp. 153-160. [cited by applicant]
Fabriek et al., The Macrophage Scavenger Receptor CD163 Functions as an Innate Immune Sensor for Bacteria; Blood, Jan. 22, 2009, vol. 113, No. 4, pp. 887-892. [cited by applicant]
Fisher et al., Membrane Fusion by Viruses and Chemical Agents; Techniques in Cellular Physiology—Part 1, 1981, vol. P115, pp. 1-36. [cited by applicant]
Fu et al., Improving CRISPZR-Cas Nuclease specificity using truncated guide RNAs. Nat. Biotechnol., Mar. 2014, vol. 32, No. 3, pp. 279-281. Epub Jan. 26, 2014. [cited by applicant]
Gaj et al., ZFN, TALEN and CRISPR/Cas-based Methods for Genome Engineering, Trends in Biotechnology, 2013, vol. 31, No. 7, pp. 397-405. [cited by applicant]
Gaudreault et al., Factors Affecting the Permissiveness of Porcine Alveolar Macrophages for Porcine Reproductive and Respiratory Syndrome Virus, Archives of Virology, 2009, vol. 154, No. 1, pp. 133-136. [cited by applicant]
Gerrits et al., 'Perspectives for Artificial Insemination and Genomics to Improve Global Swine Populations, Theriogenology, Jan. 2005, vol. 63, No. 2, pp. 283-299. [cited by applicant]
Gomez et al., Derivation of Cat Embryonic Stem-Like Cells from In Vitro-Produced Blastocysts on Homologous and Heterologous Feeder Cells; Theriogenology, (2010) vol. 74, pp. 498-515. [cited by applicant]
Graham et al., Resources for the Design of CRISPR Gene Editing Experiments, Genome Biology (2015) vol. 16, p. 260. [cited by applicant]
Graham et al., The Fusion of Cells with One- and Two-Cell Mouse Embryos; The Wistar Institute Symposium Monograph, 1969, vol. 9, pp. 19-35. [cited by applicant]
Graversen et al., Targeting the Hemoglobin Scavenger Receptor CD163 in Macrophages Highly Increases the Anti-inflammatory Potency of Dexamethasone; Molecular Therapy, 2012, vol. 20, No. 8, pp. 1550-1558. [cited by applicant]
Groenen et al., Analyses of Pig Genomes Provide Insight Into Porcine Demography and Evolution, Nature, 2012, vol. 491, No. 7424, pp. 393-398. [cited by applicant]
Hai et al., One-step Generation of Knockout Pigs by Zygote Injection of CRISPR/Cas System, Cell Research, 2014, vol. 24, No. 3, pp. 372-375. [cited by applicant]
Halbur et al., Comparison of the Pathogenicity of Two US Porcine Reproductive and Respiratory Syndrome Virus Isolates with that of the Lelystad Virus; Veterinary Pathology, 1995, vol. 32, pp. 648-660. [cited by applicant]
Hammer et al., Production of Transgenic Rabbits, Sheep and Pigs by Microinjection; Nature, Jun. 1985, vol. 315, No. 6021, pp. 680-683. [cited by applicant]
Hao et al., Production of Endothelial Nitric Oxide Synthase (eNOS) Over-Expressing Piglets; Transgenic Research, 2006, vol. 15, No. 6, pp. 739-750. [cited by applicant]
Hauschild et al., Efficient Generation of A Biallelic Knockout in Pigs Using Zinc-finger Nucleases; Proceedings of the National Academy of Sciences of the United States of America, 2011, vol. 108, No. 29, pp. 12013-1201… [cited by applicant]
Holtkamp et al., Assessment of the Economic Impact of Porcine Reproductive and Respiratory Syndrome Virus on United States Pork Producers; Journal of Swine Health and Production, Mar. and Apr. 2013a, vol. 21, No. 2, pp.… [cited by applicant]
Huang et al., Porcine DC-SIGN: Molecular Cloning, Gene Structure, Tissue Distribution and Binding Characteristics; Developmental and Comparative Immunology, 2009, vol. 33, pp. 464-480. [cited by applicant]
Hwang et al., Efficient Genome Editing in Zebrafish Using A CRISPR-Cas System; Nature Biotechnology, Mar. 2013, Jean et al., Pluripotent Genes in Avian Stem Cells; Development Growth Differentiation (2013) vol. 55, pp. … [cited by applicant]
Im et al., In Vitro Development of Preimplantation Porcine Nuclear Transfer Embryos Cultured in Different Media and Gas Atmospheres; Theriogenology, 2004, vol. 61, pp. 1125-1135. [cited by applicant]
Jeney et al., Pro—Oxidant and Cytotoxic Effects of Circulating Heme; Blood, Aug. 1, 2002, vol. 100, No. 3, pp. 879-887. [cited by applicant]
Keffaber et al., Reproductive Failure of Unknown Etiology; American Association of Swine Practitioners Newsletter, Sep.-Oct. 1989, vol. 1, No. 2, pp. 1-10. [cited by applicant]
Kim et al., Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res., Jun. 2014, vol. 24, No. 6, pp. 1012-1019. Epub Apr. 2, 2014. [cited by applicant]
Kim et al., A Guide to Genome Engineering with Programmable Nucleases, Nature Reviews. Genetics, 2014, vol. 15, No. 5, pp. 321-334. [cited by applicant]
Kim et al., Enhanced Replication of Porcine Reproductive and Respiratory Syndrome {PRRS) Virus in A Homogeneous Subpopulation of MA-104 Cell Line; Archives of Virology, 1993, vol. 133, pp. 477-483. [cited by applicant]
Kim et al., Defining the Cellular Target{s) of Porcine Reproductive and Respiratory Syndrome Virus Blocking Monoclonal Antibody 7G10, Journal of Virology, Jan. 2006, vol. 80, No. 2, pp. 689-696. [cited by applicant]
Kristiansen et al., Defining the Cellular Target{s) of Porcine Reproductive and Respiratory Syndrome Virus Blocking Monoclonal Antibody 7G10; Journal of Virology, Jan. 2006, vol. 409, No. 6817, pp. 198-201. [cited by applicant]
Kwon et al., Production of Biallelic CMP-Neu5Ac Hydroxylase Knock-out Pigs; Scientific Reports, 1981, vol. 3, pp. 1-10. [cited by applicant]
Ladinig et al., Pathogenicity of Three Type 2 Porcine Reproductive and Respiratory Syndrome Virus Strains in Experimentally Inoculated Pregnant Gills, Virus Research, 2015, vol. 203, pp. 24-35. [cited by applicant]
Lager et al., Evaluation of Protective Immunity in Gilts Inoculated with the NADC-8 Isolate of Porcine Reproductive and Respiratory Syndrome Virus {PRRSV) and Challenge-Exposed with an Antigenically Distinct PRRS\Isolal… [cited by applicant]
Lai et al., Generation of Cloned Transgenic Pigs Rich in Omega-3 Fatty Acids; Nature Biotechnology, Apr. 2006, vol. 24, No. 4, pp. 435-436. [cited by applicant]
Lai et al., Production of alpha-1,3-Galactosyltransferase Knockout Pigs by Nuclear Transfer Cloning; Science, 2002, vol. 295, No. 82, pp. 1089-1092. [cited by applicant]
Lai et al., Creating Genetically Modified Pigs by Using Nuclear Transfer, Reproductive Biology and Endocrinology, 2003, vol. 1, No. 82, pp. 1-6. [cited by applicant]
Lai et al., Methods Paper—Production of Cloned Pigs by Using Somatic Cells as Donors; Cloning and Stem Cells, 2003, vol. 5, No. 4, pp. 233-241. [cited by applicant]
Lai et al., A Method for Producing Cloned Pigs by Using Somatic Cells as Donors; Methods in Molecular Biology, 2004, vol. 254, pp. 149-163. [cited by applicant]
Lawson et al., Porcine Reproductive and Respiratory Syndrome Virus Infection of Gnotobiotic Pigs: Sites of Virus replication and Co-localization with MAC-387 Staining at 21 Days Post-infection; Virus Research, 1997, vol… [cited by applicant]
Lee et al., Engraftment of Human iPS Cells and Allogeneic Porcine Cells into Pigs with Inactivated RAG2 and Accompanying Severe Combined Immunodeficiency, Proceedings of the National Academy of Sciences of the United St… [cited by applicant]
Lee et al., Piglets Produced from Cloned Blastocysts Cultured In Vitro with GM-CSF; Molecular Reproduction and Development, 2013, vol. 80, No. 2, pp. 145-154. [cited by applicant]
Li et al., Heritable Gene Targeting in the Mouse and Rat Using A CRISPR-Cas System; Nature Biotechnology, vol. 31, No. 8, pp. 681-683. [cited by applicant]
Li et al., Cloned Transgenic Swine Via In Vitro Production and Cryopreservation; Biology of Reproduction, 2006, vol. 75, pp. 226-230. [cited by applicant]
Lillico et al., Live Pigs Produced From Genome Edited Zygotes, Scientific Reports, 2013, vol. 3, No. 2847, pp. 1-4. [cited by applicant]
Lunney et al., Genetic Control of Host Resistance to Porcine Reproductive and Respiratory Syndrome Virus PRRSV) Infection; Virus Research, 2010, vol. 154, pp. 161-169. [cited by applicant]
Machaty et al., Development of Early Porcine Embryos In Vitro and In Vivo; Biology of Reproduction, 1998, vol. 59, pp. 451-455. [cited by applicant]
Madsen et al., Molecular Characterization of the Haptoglobin-Hemoglobin Receptor CD163; The Journal of Biological Chemistry, Dec. 3, 2004, vol. 279, No. 49, pp. 51561-51567. [cited by applicant]
Mansour et al., Disruption of the Proto-Oncogene int-2 in Mouse Embryo-Derived Stem Cells: A General Strategy for Targeting Mutations to Nonselectable Genes; Nature, 1988,, vol. 336, pp. 348-352. [cited by applicant]
Mayes et al., Parthenogenic Activation of Pig Oocytes by Protein Kinase Inhibition; Biology of Reproduction, 1995, vol. 53, No. 2, pp. 270-275. [cited by applicant]
McGrath et al., Nuclear Transplantation in the Mouse Embryo by Microsurgery and Cell Fusion; Science, Jun. 1983, vol. 220, No. 4603, pp. 1300-1302. [cited by applicant]
Meng et al., Heterogeneity of Porcine Reproductive and Respiratory Syndrome Virus: Implications for Current Vaccine Efficacy and Future Vaccine Development [Review]; Veterinary Microbiology, 2000, vol. 74, No. 4, pp. 30… [cited by applicant]
Meng et al., Sequence Comparison of Open Reading Frames 2 to 5 of Low and High Virulence United States Isolates of Porcine Reproductive and Respiratory Syndrome Virus; Journal of General Virology, 1995, vol. 76, No. 3, … [cited by applicant]
Mengeling et al., Identification and Clinical Assessment of Suspected Vaccine-Related Field Strains of Porcine Reproductive and Respiratory Syndrome Virus; American Journal of Veterinary Research, 1999, vol. 60, No. 3, … [cited by applicant]
Merck et al., Normal Rectal Temperature Ranges chart, The Merck Veterinary Manual 2009-2015, accessed rom http://www.merckvetmanual.com/mvm/appendixes/reference_guides/normal_rectal_temperature_ranges.html?qt=normal%20r… [cited by applicant]
Miao et al., Centrosome Abnormalities During Porcine Oocyte Aging; Environmental and Molecular Mutagenesis, 2009, vol. 50, pp. 666-671. [cited by applicant]
Misinzo et al., Involvement of Proteases in Porcine Reproductive and Respiratory Syndrome Virus Uncoating Upon Internalization in Primary Macrophages; Veterinary Research, 2008, vol. 39, No. 55, 14-pages. [cited by applicant]
Molitor et al., Immunity to PRRSV—Double-Edged Sword; Veterinary Microbiology, 1997,, vol. 55, No. 1-4, pp. 265-276. [cited by applicant]
Morgan et al., Pathology and Virus Distribution in the Lung and Lymphoid Tissues of Pigs Experimentally Inoculated with Three Distinct Type 1 PRRS Virus Isolates of Varying Pathogenicity; Transboundary and Emerging Dise… [cited by applicant]
Munoz et al., Conventional Pluripotency Markers Are Unspecific for Bovine Embryonic-Derived Cell-Lines; Theriogenology (2008) vol. 69, pp. 1159-1164. [cited by applicant]
Murtaugh et al., Comparison of the Structural Protein Coding Sequences of the VR-2332 and Lelystad Virus Strains of the PRRS Virus; Archives of Virology, 1995, vol. 140, No. 8, pp. 1451-1460. [cited by applicant]
Nath et al., The Amino-Terminal Immunoglobulin-Like Domain of Sialoadhesin Contains the Sialic Acid Binding 36 Site, Comparison with CD22; The Journal of Biological Chemistry, 1995, vol. 270, Part 2, pp. 26184-26191. [cited by applicant]
Nauwynck et al., Entry of Porcine Reproductive and Respiratory Syndrome Virus into Porcine Alveolar Macrophages Via Receptor-Mediated Endocytosis; Journal of General Virology, 1999, vol. 80, Part 2, pp. 297-305. [cited by applicant]
Nelsen et al., Porcine Reproductive and Respiratory Syndrome Virus Comparison: Divergent Evolution on Two Continents; Journal of Virology, Jan. 1999, vol. 73, No. 1, pp. 270-280. [cited by applicant]
Nielsen et al., Generation of an Infectious Clone of VR-2332, A Highly Virulent North American-Type Isolate of Porcine Reproductive and Respiratory Syndrome Virus; Journal of Virology, Mar. 2003, vol. 77, No. 6, pp. 370… [cited by applicant]
Nielsen et al., The Macrophage Scavenger Receptor CD163: Endocytic Properties of Cytoplasmic Tail Variants; Journal of Leukocyte Biology, Apr. 2006, vol. 79, No. 4, pp. 837-845. [cited by applicant]
Neumann et al., Assessment of the Economic Impact of Porcine Reproductive and Respiratory Syndrome on Swine Production in the United States; Journal of the American Veterinary Medical Association, Aug. 1, 2015, vol. 227… [cited by applicant]
Niemann et al., Transgenic Farm Animals Get Off the Ground; Transgenic Research (1998) vol. 7, pp. 73-75. [cited by applicant]
Prather et al., W830: CRISPR/Cas9-Medicated Generic Engineering: Is DC163 an Entry Mediator for PRRSv Infection? Plant & Animal Genome XXIII, Jan. 10-14, 2015, San Diego, CA; Abstract. [cited by applicant]